Third meningitis case recorded
The Rhode Island Department of Health has identified the state’s third case of illness linked to the nationwide fungal meningitis outbreak. The patient, a male in his 50s from Warwick, received a spinal epidural injection at Ocean State Pain Management on Sept. 22 from one of the three contaminated lots. The patient sought care at an area hospital today and is being treated.
Two Rhode Island facilities – Ocean State Pain Management, with offices in Woonsocket and East Greenwich, and New England Anesthesiologists of Warwick – received medication from any of three lots recalled by New England Compounding Center of Framingham, Mass. These lots have been linked to a multistate outbreak of meningitis following epidural steroid injection. Additional lots of the medication, although not linked to the outbreak at this time, have also been recalled.
In total, 266 patients in Rhode Island received the recalled medication. This type of meningitis is not transmitted from person to person. Only patients who received an epidural steroid injection containing medication from one of these recalled lots should contact their healthcare provider if they experience symptoms such as fever, headache, stiff neck, sensitivity to light, slurred speech, difficulty walking or increased dizziness. Patients should also seek care if they have worsening pain, redness or swelling at the injection site.
The two other people from Rhode Island who were diagnosed with fungal meningitis was a woman in her 60s from Lincoln and a woman from Providence Country in her 40s.